ACE2 and thyroid cancer: ACE2 mRNA expression was described to be increased in renal papillary cell carcinoma and colon and pancreatic adenocarcinomas, and decreased in kidney chromophobe, testicular germ cell tumours, and thyroid cancer [7,8,9].